Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL)

R Bech, J. Baumgartner-Nielsen, NA Peterslund, Torben Steiniche, K Bange, M Deleuran, F d'Amore

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind110
Udgave nummer11
ISSN0006-4971
StatusUdgivet - 2007

Citer dette

Bech, R., Baumgartner-Nielsen, J., Peterslund, NA., Steiniche, T., Bange, K., Deleuran, M., & d'Amore, F. (2007). Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL). Blood, 110(11).
Bech, R ; Baumgartner-Nielsen, J. ; Peterslund, NA ; Steiniche, Torben ; Bange, K ; Deleuran, M ; d'Amore, F. / Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL). I: Blood. 2007 ; Bind 110, Nr. 11.
@article{9a20f4c0023b11dd9e03000ea68e967b,
title = "Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL)",
author = "R Bech and J. Baumgartner-Nielsen and NA Peterslund and Torben Steiniche and K Bange and M Deleuran and F d'Amore",
year = "2007",
language = "English",
volume = "110",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

Bech, R, Baumgartner-Nielsen, J, Peterslund, NA, Steiniche, T, Bange, K, Deleuran, M & d'Amore, F 2007, 'Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL)', Blood, bind 110, nr. 11.

Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL). / Bech, R; Baumgartner-Nielsen, J.; Peterslund, NA; Steiniche, Torben; Bange, K; Deleuran, M; d'Amore, F.

I: Blood, Bind 110, Nr. 11, 2007.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL)

AU - Bech, R

AU - Baumgartner-Nielsen, J.

AU - Peterslund, NA

AU - Steiniche, Torben

AU - Bange, K

AU - Deleuran, M

AU - d'Amore, F

PY - 2007

Y1 - 2007

M3 - Journal article

VL - 110

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -